Investment
Features
FeesSafety
Academy
More
Pluang+

NVE Corporation rated Buy for strong growth in medical sensors and high profitability.

Analyst Insights
12 Oct 2026
Seeking Alpha
View Source
Bullish
NVE Corporation rated Buy for strong growth in medical sensors and high profitability.

NVE Corporation (NVEC) is rated a long-term Buy due to its proprietary spintronics technology and expanding presence in the medical-device market. The company supplies ultraminiature magnetic sensors for implantable medical devices, working with major manufacturers like Abbott Laboratories. NVEC reported a net profit margin of 58% in FY2026, with Q1 FY2027 revenue and net income rising 81% and 79%, showing strong growth momentum. Despite a premium valuation, its high margins, cash flow, and 3.57% dividend yield support the positive outlook, assuming continued earnings growth.

NVE Corporation's medical-sensor innovation is the subject, with Pluang market data as context. As of Oct 12, 2026 20:02 WIB, among 128 priced Health-sector US stocks tradable on Pluang, 65 rose and 44 fell. Notable movers include Bristol-Myers Squibb Co (BMY) at USD 60.99 with a 3.16% increase and Medtronic PLC (MDT) at USD 90.60 up 2.40%, while Ginkgo Bioworks Holdings Inc (DNA) declined 2.35%. The most notable figure is BMY's 3.16% gain.

More News

Integrated Power Services acquires Bold Renewables to enhance solar inverter service capabilities.

Integrated Power Services acquires Bold Renewables to enhance solar inverter service capabilities.

Integrated Power Services (IPS) has acquired Bold Renewables, the exclusive OEM provider of parts and field services for Advanced Energy solar inverters. This acquisition strengthens IPS's renewable energy platform by adding specialized inverter life...

Company Fundamentals
Bullish
1 hour ago
Complicated urinary tract infections market to grow by 2036, boosted by new drug approvals and rising antimicrobial resistance

Complicated urinary tract infections market to grow by 2036, boosted by new drug approvals and rising antimicrobial resistance

The complicated urinary tract infections (cUTI) market is projected to expand steadily through 2036, driven by increasing antimicrobial resistance, higher rates of recurrent and hospital-acquired infections, and more patients with underlying conditio...

Market News
Bullish
1 hour ago
GlobaleSIM offers convenient eSIM options for seamless mobile internet in Japan travel.

GlobaleSIM offers convenient eSIM options for seamless mobile internet in Japan travel.

GlobaleSIM highlights the benefits of using eSIM technology for travelers visiting Japan, enabling easy access to mobile internet without the need to swap physical SIM cards. This service supports Japan's local 4G/5G networks, providing reliable nati...

Others
Neutral
1 hour ago
Bloom Energy stock dropped 20%+ five times since Sept 2025, rebounding quickly each time.

Bloom Energy stock dropped 20%+ five times since Sept 2025, rebounding quickly each time.

Since September 2025, Bloom Energy's stock has fallen by 20% or more on five separate occasions. Despite these sharp declines, the stock has managed to recover from four of these drops within a few weeks, indicating volatility but also resilience. Th...

Analyst Insights
Neutral
3 hours ago
Alignment Health launches Medicare Advantage plan for Asian American seniors in LA and Orange counties

Alignment Health launches Medicare Advantage plan for Asian American seniors in LA and Orange counties

Alignment Health Plan introduced Central Health Harmony, a new Medicare Advantage plan starting January 1, 2027, targeting Asian American seniors in Los Angeles and Orange counties. The plan offers access to over 600 physicians who speak Chinese, Kor...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App